SciLux podcast – Ibrahim Boussaad, research scientist at LCSB

08 November 2022

Home » Research News » SciLux podcast – Ibrahim Boussaad, research scientist at LCSB

Parkinson’s disease

Luxembourg is nowadays one of the leading locations for Parkinson’s research. It is thanks to Dr. Ibrahim Boussaad’s work, among several other projects, who recently received an award for the first proof-of-concept for precision medicine related to this neurodegenerative disease.

How to identify key mechanism of Parkinson’s disease?

Parkinson’s disease is a neurodegenerative disease that we are not able to stop at the moment. Dr Ibrahim Boussaad, research scientist at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, is working in this field of research for several years. With his research group, he has made a significant contribution to the knowledge and understanding of this disease, enabling considerable advances in potential new treatments.

Listen to Dr Ibrahim Boussaad, research scientist at LCSB and learn more about research on Parkinson’s disease run in Luxembourg.

A first proof of concept for precision medicine in the field of neurodegenerative diseases

On Thursday, 20 October, Dr Ibrahim Boussaad, together with Prof. Rejko Krüger, head of the Translational Neuroscience group at the LCSB and director of Transversal Translational Medicine at the Luxembourg Institute of Health (LIH), received the 2022 FNR Award for Outstanding Scientific Achievement.

The award was attributed to the two scientists and their team for the first proof-of-concept for precision medicine in Parkinson’s disease. This long-term translational research project resulted in the publication of scientific articles in well-known peer-reviewed journals, patents granted at the national and European level and the set-up of an inter-institutional infrastructure (LCSB, LIH) for early drug discovery that is now available to all researchers and industrial partners in Luxembourg and beyond.

Luxembourg: a leading location for Parkinson’s research

Parkinson’s disease is an important topic of research in Luxembourg. Over the past two decades, Luxembourg has developed into an internationally recognised hub for Parkinson’s research. The country is now one of the leading locations for this field of research. This can be attributed in part to the FNR-sponsored (Luxembourg National Research Fund) project NCER-PD, the National Centre for Excellence in Research on Parkinson’s Disease.

A podcast to highlight research made in Luxembourg

Research Luxembourg, RTL Today and SciLux have teamed up to launch a new series of podcasts showcasing science in Luxembourg and beyond.

With a new episode every 2 weeks published on RTL Play, ‘SciLux powered by Research Luxembourg’ will showcase research activities and scientific cooperation in the Grand Duchy.

Learn more on the SciLux X Research Luxembourg podcast